Pharma R&D productivity dips, but efficiency gains give hope
Clarivate
JANUARY 23, 2024
forecast peak sales per asset versus the cost of developing an asset or an output measure such as the number of global first world launches). In addition, R&D productivity analyses are in some way associated with actual or future launches or a consequence of the launch, such as resulting sales.
Let's personalize your content